McKesson cash flow statement
In fiscal 2026, McKesson's operations generated $6.16bn of cash; it spent $436m on capital projects, leaving free cash flow of $5.72bn. It returned $381m in dividends and $4.75bn through buybacks.
Cash flow statement
| Fiscal year | 2010Mar 2010 | 2011Mar 2011 | 2012Mar 2012 | 2013Mar 2013 | 2014Mar 2014 | 2015Mar 2015 | 2016Mar 2016 | 2017Mar 2017 | 2018Mar 2018 | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2,316 | 2,338 | 2,950 | 2,483 | 3,136 | 3,112 | 3,672 | 4,744 | 4,345 | 4,036 | 4,374 | 4,542 | 4,434 | 5,159 | 4,314 | 6,085 | 6,155 | 6,853 |
| Depreciation and amortisation | 477 | 496 | 493 | 581 | 735 | 1,017 | 885 | 910 | 951 | 317 | 335 | 344 | 312 | 272 | 279 | 272 | 287 | 325 |
| Stock-based pay | 114 | 137 | 154 | 167 | 160 | 174 | 123 | 115 | 69 | 95 | 119 | 151 | 161 | 162 | 182 | 226 | 247 | 259 |
| Capital spending | 199 | 233 | 221 | 241 | 278 | 376 | 488 | 404 | 405 | 426 | 362 | 451 | 388 | 390 | 431 | 537 | 436 | 437 |
| Free cash flow | 2,117 | 2,105 | 2,729 | 2,242 | 2,858 | 2,736 | 3,184 | 4,340 | 3,940 | 3,610 | 4,012 | 4,091 | 4,046 | 4,769 | 3,883 | 5,548 | 5,719 | 6,416 |
| Free cash flow after stock pay | 2,003 | 1,968 | 2,575 | 2,075 | 2,698 | 2,562 | 3,061 | 4,225 | 3,871 | 3,515 | 3,893 | 3,940 | 3,885 | 4,607 | 3,701 | 5,322 | 5,472 | 6,157 |
| Dividends paid | 131 | 171 | 195 | 194 | 214 | 227 | 244 | 253 | 262 | 292 | 294 | 276 | 277 | 292 | 314 | 345 | 381 | 393 |
| Share buybacks | 323 | 2,050 | 1,874 | 1,214 | 130 | 450 | 1,612 | 2,311 | 1,709 | 1,639 | 1,934 | 742 | 3,516 | 3,638 | 3,025 | 3,146 | 4,750 | 6,699 |
| Shares issued | 212 | 367 | 167 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2,100 | −2,383 | 7,748 | −918 | 2,420 | 1,232 | 3,421 | −220 |
| Depreciation and amortisation | 163 | 153 | −213 | 157 | 188 | 188 | −246 | 195 |
| Stock-based pay | 63 | 53 | 54 | 55 | 68 | 58 | 66 | 67 |
| Capital spending | 136 | 126 | 169 | 111 | 106 | 108 | 111 | 112 |
| Free cash flow | 1,964 | −2,509 | 7,579 | −1,029 | 2,314 | 1,124 | 3,310 | −332 |
| Free cash flow after stock pay | 1,901 | −2,562 | 7,525 | −1,084 | 2,246 | 1,066 | 3,244 | −399 |
Compare with peers
- Cencora cash flow
- Henry Schein cash flow
- 111, Inc. cash flow
- Cosmos Health Inc. cash flow
- Cellyan Biotechnology Co., Ltd cash flow
Head to head: COR vs MCKHSIC vs MCKMCK vs YI
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies